COMMUNIQUÉS West-GlobeNewswire

Oasmia Pharmaceutical AB (publ) Interim report for the period May 1 – July 31, 2019
26/09/2019
EVENTS IN FIRST QUARTER Oasmia presented results from two clinical studies of Docecal in patients with metastatic breast cancer The Board of Directors appointed a special examiner to give all shareholders basis for [...]
ASIT biotech Firmly on Course for Readout of Phase III Clinical Study in Grass Pollen Allergy
26/09/2019
The Company has passed the Last Patient Last Visit (LPLV) milestone in the pivotal gp-ASIT+™ Phase III trial and remains on track to deliver primary efficacy results in December 2019. ASIT biotech is collaborating with [...]
Monalizumab to advance to Phase III in head and neck cancer
26/09/2019
Marseille, France, September 26, 2019, 7:00 AM CEST Innate Pharma SA (the “Company” or “Innate” - Euronext Paris: FR0010331421 – IPH), today announced that AstraZeneca (LSE/STO/NYSE: AZN) will advance monalizumab into a [...]
Monalizumab va entrer en Phase III dans le cancer de la tête et du cou
26/09/2019
Marseille, 26 septembre 2019, 7h00 Innate Pharma SA (« Innate » ou la « Société » - Euronext Paris : FR0010331421 – IPH) a annoncé aujourd’hui qu’AstraZeneca (LSE/STO/NYSE: AZN) a décidé de tester monalizumab dans un [...]
Acacia Pharma Announces New BARHEMSYS® PDUFA Target Date of 26 February 2020
26/09/2019
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014. Cambridge, UK and Indianapolis, US – 26 September 2019: Acacia Pharma Group plc (“Acacia [...]
Following Record Q2 Results, Nova Leap Health Corp. Announces Execution of Definitive Agreement to Acquire Home Care Business in Massachusetts
25/09/2019
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN HALIFAX, Nova Scotia, Sept. 25, 2019 (GLOBE NEWSWIRE) -- NOVA [...]
Emergent BioSolutions Awarded $20 Million to Develop Diazepam Auto-Injector to Treat Nerve Agent-Induced Seizures for U.S. Department of Defense
25/09/2019
GAITHERSBURG, Md., Sept. 25, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that it has been awarded approximately $20 million to develop and manufacture an auto-injector containing [...]
Dova Pharmaceuticals to Present at 2019 Cantor Global Healthcare Conference
25/09/2019
DURHAM, N.C., Sept. 25, 2019 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA) today announced that Jason Hoitt, Chief Commercial Officer, will present a company overview at the 2019 Cantor Global Healthcare [...]
Myriad Genetics Expands Board of Directors with Two Additional Members
25/09/2019
Colleen F. Reitan and Lee N. Newcomer, M.D., Elected to Myriad’s Board of Directors SALT LAKE CITY, Sept. 25, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN, “Myriad” or the “Company”), a global leader in [...]
Dentsply Sirona Announces Appointment of Janet Vergis as New Board Member
25/09/2019
CHARLOTTE, N.C., Sept. 25, 2019 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), the Dental Solutions Company, today announced that Janet S. Vergis has been appointed to its Board of [...]
Xenon Pharmaceuticals to Present at the 2019 Cantor Global Healthcare Conference
25/09/2019
BURNABY, British Columbia, Sept. 25, 2019 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage biopharmaceutical company, today announced that Dr. Simon Pimstone, Xenon's Chief Executive [...]
AGTC to Present at Upcoming Conferences
25/09/2019
GAINESVILLE, Fla., and CAMBRIDGE, Mass., Sept. 25, 2019 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus ( [...]
Axovant Gene Therapies to Present at 2019 Cell & Gene Meeting on the Mesa
25/09/2019
BASEL, Switzerland, Sept. 25, 2019 (GLOBE NEWSWIRE) -- Axovant Gene Therapies Ltd. (Nasdaq: AXGT), a clinical-stage company developing innovative gene therapies, today announced that Parag Meswani, Pharm.D., senior vice [...]
Helius Medical Technologies, Inc. and HealthTech Connex Announce Grand Opening of Canada’s Fifth PoNS Treatment™ Clinic
25/09/2019
Demand for traumatic brain injury management brings revolutionary neurological health technologies to Canada’s capital OTTAWA, Sept. 25, 2019 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. and HealthTech Connex, [...]
Auxly Closes C$123 Million Investment and R&D Partnership with Imperial Brands and Strengthens its Board
25/09/2019
VANCOUVER, British Columbia, Sept. 25, 2019 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V: XLY) (OTCQX: CBWTF) (“ Auxly ” or the “ Company ”) today announced that its transaction (the “ Transaction ”) with [...]
Supernus to Present at the 2019 Cantor Global Healthcare Conference
25/09/2019
ROCKVILLE, Md., Sept. 25, 2019 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system [...]
Guerbet: 2019 half-year results
25/09/2019
2019 half-year results Activity growth Reported revenue of €400.6 million, up 2.8%, in line with the annual objectives Revenue of €396.5 million at constant exchange rates, up 1.8% Results in line with GEAR 2023 €61.6 [...]
GUERBET: Résultats semestriels 2019
25/09/2019
Résultats semestriels 2019 Croissance de l’activité Chiffre d’affaires publié de 400,6 M€ en progression de 2,8%, conformément aux objectifs annuels Chiffre d’affaires à taux de change constant de 396,5 M€ en [...]
EssilorLuxottica: 2019 Capital Markets Day - EssilorLuxottica is uniquely positioned to transform and accelerate the industry through its open business model
25/09/2019
2019 Capital Markets Day EssilorLuxottica is uniquely positioned to transform and accelerate the industry through its open business model Integration well under way with progress in several areas and initial decisions [...]

Pages